“This First-in-Human Study shows DurAVRTM THV restored normal, pre-disease blood flow”
Good-bye SAVR!
This will be huge when it gets to market and will be bigger then $10B by 2028 because it will eliminate the need for open heart surgery.
Ann: DurAVR First in Human Study 12 Month Results, page-5
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.87 |
Change
-0.130(1.30%) |
Mkt cap ! $209.4M | |||
| Open | High | Low | Value | Volume |
| $10.00 | $10.00 | $9.80 | $28.95K | 2.947K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 234 | $9.81 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.87 | 47 | 2 |
View Market Depth
| Last trade - 13.05pm 11/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |